SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-074375
Filing Date
2019-12-19
Accepted
2019-12-19 16:16:50
Documents
7
Period of Report
2019-12-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm1926556d2_8k.htm 8-K 27890
2 EXHIBIT 4.1 tm1926556d2_ex4-1.htm EX-4.1 92655
3 EXHIBIT 4.2 tm1926556d2_ex4-2.htm EX-4.2 96386
4 EXHIBIT 5.1 tm1926556d2_ex5-1.htm EX-5.1 9066
5 EXHIBIT 10.1 tm1926556d2_ex10-1.htm EX-10.1 211008
6 EXHIBIT 99.1 tm1926556d2_ex99-1.htm EX-99.1 11452
7 GRAPHIC tm1926556d2_ex5-1img001.jpg GRAPHIC 5080
  Complete submission text file 0001104659-19-074375.txt   456908
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Filer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36020 | Film No.: 191296003
SIC: 2834 Pharmaceutical Preparations